136 related articles for article (PubMed ID: 19375609)
1. Glutathione peroxidase 3 gene polymorphisms and risk of differentiated thyroid cancer.
Lin JC; Kuo WR; Chiang FY; Hsiao PJ; Lee KW; Wu CW; Juo SH
Surgery; 2009 May; 145(5):508-13. PubMed ID: 19375609
[TBL] [Abstract][Full Text] [Related]
2. Functional glutathione peroxidase 3 polymorphisms associated with increased risk of Taiwanese patients with gastric cancer.
Wang JY; Yang IP; Wu DC; Huang SW; Wu JY; Juo SH
Clin Chim Acta; 2010 Oct; 411(19-20):1432-6. PubMed ID: 20576521
[TBL] [Abstract][Full Text] [Related]
3. FOXE1 association with differentiated thyroid cancer and its progression.
Penna-Martinez M; Epp F; Kahles H; Ramos-Lopez E; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Holzer K; Bechstein WO; Zeuzem S; Vorländer C; Badenhoop K
Thyroid; 2014 May; 24(5):845-51. PubMed ID: 24325646
[TBL] [Abstract][Full Text] [Related]
4. Investigation of VEGF and IL-8 Gene Polymorphisms in Patients with Differentiated Thyroid Cancer.
Kilic I; Guldiken S; Sipahi T; Palabiyik O; Akker M; Celik O; Soysal-Atile N; Tuncbilek N; Guven HM; Gundogdu AS; Sut N
Clin Lab; 2016 Dec; 62(12):2319-2325. PubMed ID: 28164553
[TBL] [Abstract][Full Text] [Related]
5. Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma.
Xu L; Morari EC; Wei Q; Sturgis EM; Ward LS
J Clin Endocrinol Metab; 2012 Jun; 97(6):1913-21. PubMed ID: 22438227
[TBL] [Abstract][Full Text] [Related]
6. Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinoma.
Xu L; Doan PC; Wei Q; Liu Y; Li G; Sturgis EM
Thyroid; 2012 Jan; 22(1):35-43. PubMed ID: 22136207
[TBL] [Abstract][Full Text] [Related]
7. Association between FOXP3 gene polymorphisms and risk of differentiated thyroid cancer in Chinese Han population.
Jiang W; Zheng L; Xu L; Zhang Y; Liu X; Hu L; Wang X
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27892628
[TBL] [Abstract][Full Text] [Related]
8. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.
Santos LS; Gomes BC; Gouveia R; Silva SN; Azevedo AP; Camacho V; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
Oncol Rep; 2013 Nov; 30(5):2458-66. PubMed ID: 23982724
[TBL] [Abstract][Full Text] [Related]
9. Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis.
Sturgis EM; Zhao C; Zheng R; Wei Q
Laryngoscope; 2005 Jun; 115(6):938-45. PubMed ID: 15933498
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis.
Ho T; Zhao C; Zheng R; Liu Z; Wei Q; Sturgis EM
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):756-61. PubMed ID: 16847185
[TBL] [Abstract][Full Text] [Related]
11. Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.
Pellé L; Cipollini M; Tremmel R; Romei C; Figlioli G; Gemignani F; Melaiu O; De Santi C; Barone E; Elisei R; Seiser E; Innocenti F; Zanger UM; Landi S
Arch Toxicol; 2016 Dec; 90(12):3099-3109. PubMed ID: 26783003
[TBL] [Abstract][Full Text] [Related]
12. OPN -443C>T genetic polymorphism and tumor OPN expression are associated with the risk and clinical features of papillary thyroid cancer in a Chinese cohort.
Mu G; Wang H; Cai Z; Ji H
Cell Physiol Biochem; 2013; 32(1):171-9. PubMed ID: 23867349
[TBL] [Abstract][Full Text] [Related]
13. Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma.
Zhang F; Xu L; Wei Q; Song X; Sturgis EM; Li G
Surgery; 2013 May; 153(5):711-7. PubMed ID: 23218882
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the oxidative stress-related genes ALOX5, ALOX5AP, GPX1, GPX3 and MPO for contribution to the risk of type 2 diabetes mellitus in the Han Chinese population.
Liu D; Liu L; Hu Z; Song Z; Wang Y; Chen Z
Diab Vasc Dis Res; 2018 Jul; 15(4):336-339. PubMed ID: 29383971
[TBL] [Abstract][Full Text] [Related]
15.
Radic Savic Z; Coric V; Vidovic S; Vidovic V; Becarevic J; Milovac I; Reljic Z; Mirjanic-Azaric B; Skrbic R; Gajanin R; Matic M; Simic T
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629712
[TBL] [Abstract][Full Text] [Related]
16. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population.
Wei WJ; Lu ZW; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
Int J Mol Sci; 2014 Nov; 15(11):20968-81. PubMed ID: 25405731
[TBL] [Abstract][Full Text] [Related]
17. Increased T-allele frequency of 677 C>T polymorphism in the methylenetetrahydrofolate reductase gene in differentiated thyroid carcinoma.
Ozdemir S; Silan F; Hasbek Z; Uludag A; Atik S; Erselcan T; Ozdemir O
Genet Test Mol Biomarkers; 2012 Jul; 16(7):780-4. PubMed ID: 22536880
[TBL] [Abstract][Full Text] [Related]
18. Glutathione peroxidase 3 gene polymorphisms and the risk of sudden sensorineural hearing loss.
Chien CY; Huang TY; Tai SY; Chang NC; Wang HM; Wang LF; Ho KY
Kaohsiung J Med Sci; 2017 Jul; 33(7):359-364. PubMed ID: 28738977
[TBL] [Abstract][Full Text] [Related]
19. Association Studies Between XRCC1, XRCC2, XRCC3 Polymorphisms and Differentiated Thyroid Carcinoma.
Yan L; Li Q; Li X; Ji H; Zhang L
Cell Physiol Biochem; 2016; 38(3):1075-84. PubMed ID: 26938431
[TBL] [Abstract][Full Text] [Related]
20. FOXE1 Polymorphism Interacts with Dietary Iodine Intake in Differentiated Thyroid Cancer Risk in the Cuban Population.
Ren Y; Lence-Anta JJ; Pereda CM; Chappe M; Velasco M; Infante I; Bustillo M; Turcios S; Leufroy A; Guérin T; Noël L; Lesueur F; Maillard S; Cléro E; Xhaard C; Allodji RS; Rubino C; Rodriguez R; Ortiz RM; de Vathaire F
Thyroid; 2016 Dec; 26(12):1752-1760. PubMed ID: 27610545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
